Related Experiment Video
Updated: Jun 2, 2026

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
Published on: September 6, 2012
Securing the U.S. nucleic acid synthesis industry: a case for safe-harbor information sharing
Meghan J Seltzer1, Alice R Isenberg1, Ayanna Flegler1
1The MITRE Corporation, McLean, VA, United States.
Current US guidelines for synthetic nucleic acid screening lack clear requirements, creating security vulnerabilities. A safe harbor information sharing network could enhance biosecurity by enabling better detection of threats and improving policy development.
Area of Science:
- Biosecurity
- Synthetic Biology
- Information Science
Background:
- The U.S. has issued guidelines for synthetic nucleic acid providers to screen order sequences and customers.
- These guidelines lack clear, enforceable requirements, leading to inconsistent implementation and potential vulnerabilities.
Purpose of the Study:
- To propose a safe harbor information sharing network as a biosecurity measure.
- To address the limitations of current screening guidelines for synthetic nucleic acid providers.
Main Methods:
- Proposing a network for cross-provider analysis of order sequences and customer metadata.
- Leveraging shared data to improve detection of suspicious activities.
Main Results:
- Enhanced detection of suspicious activities through shared data analysis.
- Generation of empirical evidence to refine screening priorities and definitions of concern.
- Improved foundation for policy and guideline development.
Conclusions:
- A safe harbor information sharing network can act as a biosecurity force multiplier.
- Such a system offers a more robust and adaptable approach to managing risks in the synthetic nucleic acid industry.
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drug Products: Biologics, Biosimilars and Interchangeables
Biosynthesis of Nucleic Acids
Inhibitors of Viral Protein Synthesis
Production of Pharmaceuticals
Nuclear Export of mRNA

